SEELOS THERAPEUTICS INC (SEEL)

Seelos Announces Second Postponement of its Annual Meeting of Stockholders

/PRNewswire/ -- Seelos Therapeutics, Inc. (OTCQB: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for...

Seelos Announces Postponement of its Annual Meeting of Stockholders

/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for...

“Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential”

SEEL Stock Earnings: Seelos Therapeutics Beats Revenue for Q2 2024

SEEL stock results show that Seelos Therapeutics beat on revenue for the second quarter of 2024.

SEEL Stock Earnings: Seelos Therapeutics Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Seelos Therapeutics (NASDAQ:SEEL) just reported results for the second quarter ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!

3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers

These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases.

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of...

SEEL Stock Earnings: Seelos Therapeutics Beats EPS, Beats Revenue for Q1 2024

SEEL stock results show that Seelos Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Seelos Therapeutics Announces 1-for-8 Reverse Stock Split

/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of...

Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations

/PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!

SEEL Stock Earnings: Seelos Therapeutics Beats EPS for Q4 2023

SEEL stock results show that Seelos Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

SEEL Stock Earnings: Seelos Therapeutics Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Seelos Therapeutics (NASDAQ:SEEL) just reported results for the fourth quarter ...